在生物反应器中成熟的IPSC-CM用于MLP疾病建模
Sean A Murphy1,2, Gunsik Cho1,2, Pattraranee Limphong1
1Division of Cardiology, Department of Medicine, Department of Cell Biology, Department of Biomedical Engineering, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
bioRxiv : the preprint server for biology
|August 20, 2025
概括
肌肉LIM蛋白 (MLP) 缺乏导致扩张性心肌病 (DCM). 与体外方法不同,诱导多能干细胞衍生的心肌细胞 (iPSC-CMs) 的体内成熟成功模拟了DCM,为心脏病研究揭示了关键的见解.
科学领域:
- 心血管生物学
- 干细胞生物学
- 遗传疾病模型
背景情况:
- 肌肉LIM蛋白 (MLP) 对心肌细胞 (CM) 结构至关重要.
- 在小鼠和人类中,MLP缺乏导致扩张性心肌病 (DCM).
- 使用诱导多能干细胞衍生的心肌细胞 (iPSC-CMs) 建模DCM是由于不成熟而具有挑战性的.
研究的目的:
- 产生MLP淘汰 (MLP-KO) iPSC并将其分化为CM.
- 在DCM模型中比较体外和体内成熟环境.
- 调查体内成熟环境在iPSC-CM发展中的作用.
主要方法:
- 产生了MLP-KO小鼠IPSC并将其分化为心肌细胞.
- 使用了体外成熟技术.
- 在体内移植到免疫受损的老鼠心脏中进行成熟.
主要成果:
- 在实验室成熟的MLP-KO iPSC-CM没有表现出DCM表型.
- 在体内成熟的MLP-KO iPSC-CMs显示瘤结构和ANP上调受损,反映了DCM.
- 在iPSC-CM中重新总结DCM特征时,体内环境至关重要.
结论:
- 在体内成熟对于iPSC-CM来说至关重要,以准确地建模DCM等遗传性心脏病.
- 这项研究突显了复杂疾病模型中的体外成熟的局限性.
- 这些发现为开发新型DCM治疗策略提供了洞察力.
相关概念视频
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


